David B. Weiner - May 13, 2022 Form 4 Insider Report for INOVIO PHARMACEUTICALS, INC. (INO)

Role
Director
Signature
/s/ David B. Weiner
Stock symbol
INO
Transactions as of
May 13, 2022
Transactions value $
-$17,550
Form type
4
Date filed
5/17/2022, 04:32 PM
Previous filing
Mar 14, 2022
Next filing
Aug 11, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INO Common Stock Options Exercise +18K +2.04% 902K May 13, 2022 Direct F1
transaction INO Common Stock Sale -$17.6K -9K -1% $1.95 893K May 16, 2022 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INO Restricted Stock Unit Options Exercise $0 -18K -100% $0.00* 0 May 13, 2022 Common Stock 18K Direct F1
transaction INO Restricted Stock Unit Award $0 +19K $0.00 19K May 16, 2022 Common Stock 19K Direct F3, F4
transaction INO Common Stock Options Award $0 +28K $0.00 28K May 16, 2022 Common Stock 28K $1.89 Direct F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 13, 2022.
F2 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Reporting person intends to use the proceeds of this sale to pay taxes resulting from the recent vesting of Restricted Stock Units granted by the issuer.
F3 Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 16, 2023.
F4 This grant was made pursuant to the issuer's non-employee director compensation policy.
F5 Options to vest 100% on May 16, 2023.